Semaglutide reversed diabetes-associated cognitive decline in mice by reshaping gut microbiota and reducing hippocampal neuron loss.
12 weeksSemaglutide treatment reversed cognitive decline and reshaped gut microbiota in diabetic mice
What the researchers found
Semaglutide reversed cognitive impairment and hippocampal damage in diabetic mice, with gut microbiota identified as a key mediating mechanism.
Why it matters
If semaglutide protects the brain through gut bacteria, optimizing the microbiome could enhance its neuroprotective effects.
The numbers in context
Mice received 30 nmol/kg/day semaglutide subcutaneously for 12 weeks; increased beneficial gut bacteria; reduced hippocampal neuroinflammation.
How the study worked
Mouse model (HFD + STZ-induced DM) treated with semaglutide 30 nmol/kg daily for 12 weeks with cognitive, histological, and microbiome assessment.
Who was studied
Diabetic mice (HFD + streptozotocin model)
What this study cannot tell us
Mouse model — human gut microbiota and cognitive mechanisms may differ. Specific bacterial species driving the effect not fully characterized.
How to read the evidence
Preclinical animal study with microbiome mediation analysis — compelling mechanistic data requiring human confirmation.
When this study was published
Published in 2025, advancing the gut-brain axis understanding of GLP-1 drug benefits.
The bigger picture
This adds a gut-brain axis dimension to GLP-1 neuroprotection, connecting metabolic, microbial, and cognitive health.
Questions still open
- Which gut bacteria are most important for the neuroprotective effect?
- Would probiotics enhance semaglutide's cognitive benefits?
Common questions
Can semaglutide protect the brain?
How are gut bacteria connected to brain health?
Read the original research
Gut microbiota mediates semaglutide attenuation of diabetes-associated cognitive decline.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 22(5), e00615
Citation
Qi, Liqin; Kang, Huimin; Zeng, Feihui; Zhan, Menglan; Huang, Cuihua; Huang, Qintao; Lin, Lijing; He, Guanlian; Liu, Xiaoying; Liu, Xiaohong; Liu, Libin. (2025). Gut microbiota mediates semaglutide attenuation of diabetes-associated cognitive decline.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 22(5), e00615. https://doi.org/10.1016/j.neurot.2025.e00615